Brexit and Medicines – Two Agency View Points

By |2019-01-22T12:18:04+00:00July 31st, 2018|Categories: Insights|Tags: , , , |

Turmoil for the UK healthcare markets continues to be unsettled, with the latest resignations within the UK government. 400 centrally authorized medicines have the UK as the licenceholder. The UK is a net exporter of patient packs to the EU27: [...]